Presentació dels Hospitals
Col·labora Bipodex Col·labora

General Request for Proposals – ADDF

ALZHEIMER'S DRUG DISCOVERY FOUNDATION (ADDF)

Objecte

Topic: Alzheimer.

Destination: The ADDF provides funding to academic centers and biotechs from around the world that are advancing therapeutic and biomarker development for Alzheimer’s and related dementias.

FUNDING MECHANISMS:

  • Drug Development RFP: The ADDF provides funding to academic centers and biotechs from around the world that are advancing therapeutic and biomarker development for Alzheimer’s and related dementias.
  • Neuroimaging and CSF Biomarker Development RFP: The aim of this RFP is to further develop and validate established biomarkers for which there is a clear clinical need in Alzheimer’s disease and related dementias.
  • Prevention Pipeline RFP: The ADDF seeks to support studies of cognitive symptoms due to health conditions, comparative effectiveness research, and epidemiological studies that probe whether the use or choice of drugs alters the risk for dementia or cognitive decline.

 

Budget:

  • Drug development: up to $600,000
  • Program to accelerate clinical trials : up to $3 million
  • Neuroimaging and CSF biomarker development program: up to $600,000
  • Prevention pipeline: up to $3 million for clinical trials

Duration:

  • Drug development: 1 year, potential for follow-up funding.
  • Program to accelerate clinical trials: multi-year, potential for follow-up funding.
  • Neuroimaging and CSF biomarker development program: 1 year, potential for follow-up funding. Multi-year proposals can be considered.
  • Prevention pipeline: multi-year, potential for follow-up funding.

Are you interested in this call?

Estàs interessat?

Omple el següent formulari per rebre més informació: